通讯作者: 翁文辉, wengwenhui199005@outlook.com

DOI：10.12201/bmr.202408.00025

Application of fishbone diagram analysis method in the efficacy of anti-tumor drug formulation

• 摘要：目的:探讨基于鱼骨图分析法的配置管理应用于静脉药物配置中心抗肿瘤药物配置中的效果观察。方法:以2022年1月-2024年2月期间静脉药物配置中心抗肿瘤药物配置情况为研究对象,2022年1月-2023年1月间配置的72250组肿瘤药物为对照组,使用静脉药物配置中心常规管理模式；2023年2月-2024年2月间配置的77815组肿瘤药物为观察组,使用基于鱼骨图分析法的配置管理模式。比较两种不同管理方式下处方审核情况审核时间、不合理处方发生率、抗肿瘤药物配置情况排药时长、相同药物配置时间、药物配置错误率、药物损耗率、抗肿瘤药物发放情况药物发放时长、药物发放错误率。结果:观察组肿瘤药物处方审核时长短于对照组,研究期间不合理处方发生率较低,差异有统计学意义(P<0.05)。观察组排药时长及药物配置时长相比对照组明显缩短,药物剂量、种类等配置错误率、药物损耗率低于对照组,差异有统计学意义(P<0.05)。与对照组相比,观察组药物发放时长较短,药品发放错误率较低。结论:基于鱼骨图分析法的配置管理应用于静脉药物配置中心抗肿瘤药物配置中效果良好,降低肿瘤药物处方审核时间、排药时间、药物配置时长及药物发放时长；同时可提升药物配置中心工作质量,有效降低不合理处方发生率、药物配置错误率、药物损耗率及药物发放错误率。

  关键词： 静脉药物配置中心; 抗肿瘤药物; 鱼骨图; 药物配置质量

   

  Abstract: Objective: To explore the effect of configuration management based on fishbone diagram analysis in the configuration of antineoplastic drugs in intravenous drug configuration center.Methods: The configuration of antineoplastic drugs in the intravenous drug allocation center from January 2022 to February 2024 was taken as the research object, and 72250 groups of antineoplastic drugs were allocated from January 2022 to January 2023 as the control group, using the routine management mode of the intravenous drug allocation center. From February 2023 to February 2024, 77815 groups of tumor drugs were allocated as the observation group, and the allocation management mode based on fishbone diagram analysis was used. Compare the tumor prescription review review time, unreasonable prescription incidence, tumor drug allocation drug arrangement time, same drug allocation time, drug allocation error rate, drug loss rate, drug breakage rate and tumor drug distribution drug distribution time, drug distribution error rate under two different management methods.Results: The examination time of tumor drug prescriptions in the observation group was shorter than that in the control group, and the incidence of irrational prescriptions during the study period was lower ,The difference is statistically significant (P<0.05). Compared with the control group, the time of drug discharge and drug configuration in the observation group was significantly shorter, and the error rate of drug dosage and type, drug loss rate and drug breakage rate were lower than those in the control group,The difference is statistically significant (P<0.05). Compared with the control group, the observation group has shorter drug distribution time and lower drug distribution error rate.Conclusion: The application of configuration management based on fishbone diagram analysis in the allocation of anti-tumor drugs in intravenous drug allocation center has a good effect, which can effectively improve the work efficiency of drug allocation center and reduce the time of prescription review, drug arrangement, drug allocation and drug distribution. At the same time, it can improve the working quality of drug allocation center and effectively reduce the incidence of unreasonable prescriptions, drug allocation errors, drug loss rates, drug breakage rates and drug distribution errors.

  Key words: intravenous drug dispensing center; Antitumor drugs; Fishbone diagram; Drug configuration quality

  提交时间：2024-08-13

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 刘昱, 党亚龙. 青少年近视防控的药物研究新进展. 2022. doi: 10.12201/bmr.202210.00012

  郭慧芳, 沈沛成. 慢性肾脏病中医非药物疗法研究概述. 2024. doi: 10.12201/bmr.202409.00054

  王苑如, 胡紫馨, 谢金平, 邵蓉. 欧盟罕见病药物资格认定管理政策分析及启示. 2022. doi: 10.12201/bmr.202207.00031

  吕艳华, 崔云龙, 王康龙, 钟小云, 陈家珠. 基于公众关注主题及情感视角的药物评论数据分析研究——以帕罗西汀治疗孤独症为例. 2024. doi: 10.12201/bmr.202408.00060

  吴玉珊, 饶静静, 吴仪君, 刘莹莹. 医院药物临床试验经费管理现状及解决方案. 2024. doi: 10.12201/bmr.202406.00032

  韩优莉, 崔积钰. 基于中美日新药上市现状对比的抗肿瘤新药发展策略研究. 2021. doi: 10.12201/bmr.202106.00021

  荣红国, 邢叶一祎, 董玥, 夏如玉, 商洪才, 刘建平, 费宇彤. 政策工具视角下我国抗菌药物合理用药政策研究. 2021. doi: 10.12201/bmr.202107.00021

  孙文俊, 赵子寅, 成哲玉, 李慧宁, 祝贺. 药品集中采购政策对药品价格和使用影响的系统综述. 2023. doi: 10.12201/bmr.202303.00033

  滕佳利, 宋桂杭, 李倩, 劳颖谦, 韩优莉. 基于DIP的医保服务质量评价指标体系的构建与应用——基于德尔菲法和层次分析法. 2023. doi: 10.12201/bmr.202303.00030

  彭玉冰, 牛晓珊. NF-κB在非酒精性脂肪肝病中的药物研究进展. 2024. doi: 10.12201/bmr.202410.00006

• 序号	提交日期	编号	操作
  1	2024-07-22	bmr.202408.00025V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论